Almac Launch Biomarker Services

Almac has launched Biomarkers for biopharma, a range of solutions to support biopharma companies in adopting biomarker strategies to help them better understand their drugs, improve success rates and values, and maximize the drugs’ potentials. The biomarker services include pharmacodynamic solutions, patient selection markers, assay development and bioinformatics/biostatistics consultancy.

President and managing director of Almac’s Diagnostics division, Professor Paul Harkin, said, “With Biomarkers for biopharma, we have combined a range of key solutions that are ideally suited to growing biopharma companies. For these companies, it is of critical importance that they maximize the potential success of the drugs in their pipeline and the incorporation of a biomarker strategy enables them to do this.”